Up­dat­ed: Carl Ic­ahn pro­pos­es three new Il­lu­mi­na board mem­bers in proxy fight

A proxy fight is brew­ing at Il­lu­mi­na as ac­tivist in­vestor Carl Ic­ahn ar­gues that the DNA se­quenc­ing gi­ant is cost­ing share­hold­ers bil­lions by fol­low­ing through …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER